METHODS AND SYSTEMS FOR PRESENTING A COMBINATION TREATMENT

• US 20140275739A1
• Filed: 02/14/2014
• Published: 09/18/2014
• Est. Priority Date: 04/24/2008
• Status: Active Grant

• Current Assignee: Harvest Bio LLC
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Hyde, Roderick A., Ishikawa, Muriel Y., Leuthardt, Eric C., Levien, Royce A., Lord, Robert W., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Lowell L. Jr., Wood, Victoria Y.H.
• Granted Patent: US 9,358,361 B2
• Time in Patent Office: Days
• US Class Current: 600/27
• CPC Class Codes: A61M 2021/005 images, e.g. video
• CPC Class Codes: A61M 2021/0077 with application of chemical or pharmacological stimulus
• CPC Class Codes: A61M 21/02 for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia for massage A61H; electrotherapy A61N, e.g. applying alternating or intermittent electric currents for producing anaesthesia A61N1/36021
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 20/70 relating to mental therapies, e.g. psychological therapy or autogenous training

Abstract

Methods, computer program products, and systems are described that include accepting an indication of a schedule for administration of a bioactive agent to an individual and presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.

Claims

1-94. -94. (canceled)

95. A combination therapeutic comprising:

at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder.

96. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription anti-addiction medication, and at least one artificial sensory experience for addressing addiction.

97. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription dementia medication, and at least one artificial sensory experience for addressing dementia.

98. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription Alzheimer'"'"'s disease medication, and at least one artificial sensory experience for addressing Alzheimer'"'"'s disease.

99. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription age-related-cognitive-decline medication, and at least one artificial sensory experience for addressing age-related-cognitive-decline.

100. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription anxiety medication, and at least one artificial sensory experience for addressing anxiety.

101. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription attention disorder medication, and at least one artificial sensory experience for addressing at least one attention disorder.

102. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription central nervous system tumor medication, and at least one artificial sensory experience for addressing at least one central nervous system tumor disorder.

103. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription central nervous system tumor medication, and at least one artificial sensory experience for addressing at least one central nervous system tumor disorder.

104. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription central nervous system infection medication, and at least one artificial sensory experience for addressing at least one central nervous system infection.

105. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription depression medication, and at least one artificial sensory experience for addressing depression.

106. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription epilepsy medication, and at least one artificial sensory experience for addressing epilepsy.

107. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication that addresses at least one genetic disease of central nervous system origin, and at least one artificial sensory experience for addressing the at least one genetic disease of central nervous system origin.

108. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription hearing loss medication, and at least one artificial sensory experience for addressing hearing loss.

109. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription Huntingdon'"'"'s disease medication, and at least one artificial sensory experience for addressing Huntingdon'"'"'s disease.

110. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription multiple sclerosis medication, and at least one artificial sensory experience for addressing multiple sclerosis.

111. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription Parkinson'"'"'s disease medication, and at least one artificial sensory experience for addressing Parkinson'"'"'s disease.

112. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription stroke medication, and at least one artificial sensory experience for addressing stroke.

113. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for post-stroke rehabilitation, and at least one artificial sensory experience for addressing post-stroke rehabilitation.

114. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for post-stroke rehabilitation, and at least one artificial sensory experience for addressing post-stroke rehabilitation.

115. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription post-traumatic stress medication, and at least one artificial sensory experience for addressing post-traumatic stress.

116. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription schizophrenia medication, and at least one artificial sensory experience for addressing schizophrenia.

117. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription sleep medication, and at least one artificial sensory experience for addressing sleep.

118. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription spinal cord injury medication, and at least one artificial sensory experience for addressing spinal cord injury.

119. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription Tourette'"'"'s syndrome medication, and at least one artificial sensory experience for addressing Tourette'"'"'s syndrome.

120. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for traumatic brain injury, and at least one artificial sensory experience for addressing traumatic brain injury.

121. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for at least one vision-related disorder, and at least one artificial sensory experience for addressing the at least one vision-related disorder.

122. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for acute pain, and at least one artificial sensory experience for addressing acute pain.

123. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for chronic pain, and at least one artificial sensory experience for addressing chronic pain.

124. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for central pain syndrome, and at least one artificial sensory experience for addressing central pain syndrome.

125. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder, wherein the at least one prescription medication and the at least one artificial sensory experience are packaged together as a single unit.

126. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for addressing at least one central nervous system disorder, and at least one computer program product including at least one artificial sensory experience for addressing at least one central nervous system disorder.

127. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder, wherein the at least one artificial sensory experience is implemented using at least one head-mounted display device.

128. The combination therapeutic of claim 127 wherein the at least one head-mounted display device includes at least one of Oculus Rift or Google Glass.

132. The combination therapeutic of claim 95 wherein the at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder comprises:

at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder.

129. A combination therapeutic comprising:

at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder, wherein the combination therapeutic enhances the efficacy of the at least one prescription medication.

130. A combination therapeutic comprising:

at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder, wherein the combination therapeutic enhances patient compliance in taking the at least one prescription medication.

131. A combination therapeutic comprising:

at least one prescription medication for addressing at least one central nervous system disorder, and at least one artificial sensory experience for addressing at least one central nervous system disorder, wherein the combination therapeutic improves at least one side effect of the at least one prescription medication.

133. A method comprising:

at least one of administering or taking at least one prescription medication for addressing at least one central nervous system disorder in a therapeutic regimen that includes at least one artificial sensory experience for addressing at least one central nervous system disorder.